The Patent Finder

Hanmi Pharmaceutical Co., Ltd.

Also on record
Records under this name other than the patents Hanmi Pharmaceutical Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.

Back to Hanmi Pharmaceutical Co., Ltd.

PatentTitleStatus Expires Confidence
US 7,968,316Method for the mass production of immunoglobulin Fc region deleted initial methionine residues
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,124,094Immunoglobulin Fc fragment modified by non-peptide polymer and pharmaceutical composition comprising the same
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,476,230Insulinotropic complex using an immunoglobulin fragment
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,263,084Pharmaceutical composition for treating obesity-related disease comprising insulinotropic peptide conjugate
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,422,349N-Terminal Modified EXENDIN-4
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 11,883,402Crystalline Forms of a Quinazoline Compound and Its Hydrochloride Salts
Formerly held
In force
 · High confidence
In forceHigh confidence
US 7,737,260Protein Complex Using an Immunoglobulin Fragment and Method for the Preparation Thereof
Formerly held
Term ended
Ended no later than Aug 23, 2025 · Medium confidence
Term endedEnded no later than Aug 23, 2025Medium confidence
US 8,846,874Igg FC Fragment for a Drug Carrier and Method for the Preparation Thereof
Formerly held
Term ended
Term ended Jun 18, 2025 · Medium confidence
Term endedTerm ended Jun 18, 2025Medium confidence
US 7,736,653Pharmaceutical composition comprising an immunoglobulin Fc region as a carrier
Formerly held
Term ended
Term ended Jun 3, 2025 · From the USPTO record
Term endedTerm ended Jun 3, 2025From the USPTO record
US 8,029,789Method for the Mass Production of Immunoglobulin Constant Region
Formerly held
Term ended
Term ended Nov 13, 2024 · High confidence
Term endedTerm ended Nov 13, 2024High confidence
10 of 15 patents shown.
Pro members see all 15.
Pro members: see all 15 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited